Clinical Trial

Live Double Combined Lactobacillus Capsule for Vaginal Use（IIa）

Name: Live Double Combined Lactobacillus Capsule for Vaginal Use（IIa） — clinical trial record (NCT07418996)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: BV

Completed Phase 2

View on ClinicalTrials.gov →

Summary

This is a mutilcenter, randomized, double-blind, Metronidazole controlled phase lIa clinical study to evaluate the safety and tolerability of dual - live lactobacilli-containing vaginal capsules for the treatment of Bacterial Vaginosis.

Trial Details

NCT Number	NCT07418996
Lead Sponsor	Guangdong Longchuangji Pharmaceutical Co., Ltd.
Conditions	Bacterial Vaginosis (BV)
Enrollment	57 participants
Start Date	2021-05-18
Primary Completion	2022-07-04 (estimated)
Study Completion	2022-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-18